|

Autologous B7-H3 CAR T Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • National Cancer Institute (NCI)1

Indications

  • High-Grade Neuroendocrine Carcinoma1
  • Poorly Differentiated Neuroendocrine Carcinoma1
  • Extrapulmonary Small Cell Carcinoma1
  • Refractory Small Cell Lung Cancer1
  • Recurrent Small Cell Lung Cancer1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.